Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Asset Utilization Ratio: 2022-2025

Historic Asset Utilization Ratio for Arcutis Biotherapeutics (ARQT) over the last 3 years, with Sep 2025 value amounting to 0.88.

  • Arcutis Biotherapeutics' Asset Utilization Ratio rose 179.49% to 0.88 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.88, marking a year-over-year increase of 179.49%. This contributed to the annual value of 0.57 for FY2024, which is 277.69% up from last year.
  • As of Q3 2025, Arcutis Biotherapeutics' Asset Utilization Ratio stood at 0.88, which was up 16.19% from 0.76 recorded in Q2 2025.
  • Arcutis Biotherapeutics' 5-year Asset Utilization Ratio high stood at 0.88 for Q3 2025, and its period low was -0.00 during Q4 2022.
  • In the last 3 years, Arcutis Biotherapeutics' Asset Utilization Ratio had a median value of 0.27 in 2024 and averaged 0.36.
  • Data for Arcutis Biotherapeutics' Asset Utilization Ratio shows a peak YoY surged of 51,277.37% (in 2023) over the last 5 years.
  • Arcutis Biotherapeutics' Asset Utilization Ratio (Quarterly) stood at -0.00 in 2022, then skyrocketed by 51,277.37% to 0.16 in 2023, then spiked by 207.91% to 0.50 in 2024, then surged by 179.49% to 0.88 in 2025.
  • Its Asset Utilization Ratio stands at 0.88 for Q3 2025, versus 0.76 for Q2 2025 and 0.61 for Q1 2025.